PHARMA-BIO SERV, INC. Marketable Securities, Unrealized Gain (Loss)
PHARMA-BIO SERV, INC. (PBSV) reported Marketable Securities, Unrealized Gain (Loss) of $136.01 thousand for the 12-month period ending 2025-10-31, per its 10-K filed 2026-01-29.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-01-29
- PHARMA-BIO SERV, INC. marketable securities, unrealized gain (loss) for fiscal 2025 was $136.01K.
- PHARMA-BIO SERV, INC. marketable securities, unrealized gain (loss) for fiscal 2024 was -$17.71K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|
| 2025-10-31 | $136.01K 10-K · filed 2026-01-29 |
| 2024-10-31 | -$17.71K 10-K · filed 2026-01-29 |